Error: Could not add to watchlist. X
+ Watchlist

Neurologix Inc

NRGXQ:US
OTC US
0.00
USD
0.00
0.00%
As of 8:10 PM EST 12/7/2016
Volume
1,170
Previous Close
0.00
52Wk Range
0.00 - 0.00
1 Yr Return
1,233.33%
Volume
1,170
Previous Close
0.00
52Wk Range
0.00 - 0.00
1 Yr Return
1,233.33%
YTD Return
1,233.33%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.44
Market Cap (k USD)
69.994
Shares Outstanding (m)
27.998
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.16%
% Price Change
+1.62%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Neurologix, Inc. is developing treatments for disorders of the brain and central nervous system using gene therapy and other alternative therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease and epilepsy. Neurologix's core technology, NLX, is currently being tested in a human clinical trial to treat Parkinson's disease.
Address
One Bridge Plaza
Suite 605
Fort Lee, NJ 07024
United States
Phone
1-201-592-6451
Show More